← Back to Search

Procedure

Quatera 700 vs. Centurion for Cataract Surgery

N/A
Recruiting
Research Sponsored by Carolina Eyecare Physicians, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age: 50 to 80 years old
Potential postoperative visual acuity of 0.2 logMAR (20/32 Snellen) or better in both eyes
Must not have
Other ocular procedures at the time of the cataract extraction (i.e., iStent)
Use of any systemic or topical drug known to interfere with visual performance
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intraoperative
Awards & highlights
No Placebo-Only Group

Summary

This trial is evaluating two different devices used for cataract surgery. Cataract surgery is a common procedure that removes the cloudy lens of the eye and replaces it with an artificial lens. The study

Who is the study for?
This trial is for individuals who are scheduled to undergo routine cataract surgery in both eyes. Specific eligibility criteria details were not provided, so it's important to consult the study team for more information on who can participate.
What is being tested?
The study compares two different devices used in phacoemulsification, a common treatment for cataracts: Quatera 700 and Centurion. It aims to determine which device may be more effective or has advantages during routine cataract surgeries.
What are the potential side effects?
While specific side effects of using either Quatera 700 or Centurion aren't detailed here, typical risks of phacoemulsification include infection, bleeding, inflammation, or changes in eye pressure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 50 and 80 years old.
Select...
My vision after surgery is expected to be near normal.
Select...
I am having surgery to replace the lenses in both of my eyes.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am having other eye procedures along with my cataract surgery.
Select...
I am not using any medication that affects my vision.
Select...
I have a long-term eye inflammation.
Select...
I have had radial keratotomy surgery.
Select...
I have abnormal pupils.
Select...
I will need anesthesia beyond just surface-level for my procedure.
Select...
I have a serious eye condition affecting the cornea.
Select...
My diabetes is not under control.
Select...
I have had a cornea transplant.
Select...
I do not have any current eye infections or inflammation.
Select...
I have eye conditions like keratoconus or corneal dystrophy affecting my vision.
Select...
I do not have severe eye conditions like advanced glaucoma or macular degeneration.
Select...
I have had eye surgery before.
Select...
I have had laser-assisted cataract surgery in one eye.
Select...
I have had a retinal detachment in the past.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intraoperative
This trial's timeline: 3 weeks for screening, Varies for treatment, and intraoperative for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Lens removal time

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Quatera 700Experimental Treatment2 Interventions
Group II: Centurion Vision SystemActive Control2 Interventions

Find a Location

Who is running the clinical trial?

Carolina Eyecare Physicians, LLCLead Sponsor
10 Previous Clinical Trials
560 Total Patients Enrolled
Science in VisionOTHER
16 Previous Clinical Trials
764 Total Patients Enrolled
~14 spots leftby Jun 2025